- Title: Subtitle
- Sequential administration of high-dose interleukin-2 and ipilimumab in patients with metastatic melanoma
- Creators
- Sapna Pradyuman Patel - The University of Texas MD Anderson Cancer CenterDenai Milton - The University of Texas MD Anderson Cancer CenterMohammed M. Milhem - University of IowaLawrence E. Flaherty - Wayne State UniversitySigrun Hallmeyer - Oncology SpecialistsLynn G. Feun - University of MiamiRalph J. Hauke - Nebraska Cancer SpecialistsLee D. Cranmer - University of ArizonaGregory A. Daniels - University of California, San DiegoGary C. Doolittle - University of Kansas Medical CenterBret Taback - Columbia University Irving Medical CenterMichael Morse - Duke Medical CenterJose Lutzky - Mount Sinai Medical CenterWilliam Howard Sharfman - Johns Hopkins University
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.34(15_suppl), pp.e21041-e21041
- DOI
- 10.1200/JCO.2016.34.15_suppl.e21041
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2016
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984363301502771
Abstract
Sequential administration of high-dose interleukin-2 and ipilimumab in patients with metastatic melanoma
Journal of clinical oncology, Vol.34(15_suppl), pp.e21041-e21041
05/20/2016
DOI: 10.1200/JCO.2016.34.15_suppl.e21041
Details
Metrics
2 Record Views